Goodwin advised RA Pharmaceuticals on the deal Ra Pharmaceuticals, Inc. (NASDAQ: RARX) executed the pricing of an underwritten public offering of 8,400,000 shares of its common…
RA Pharmaceuticals’ $58 Million Common Stock Offering
Goodwin advised RA Pharmaceuticals on the deal Ra Pharmaceuticals, Inc. (NASDAQ: RARX) executed the pricing of an underwritten public offering of 8,400,000 shares of its common…